Castleview Partners, LLC Portfolio
Auto-discovered active 13F filer.
SEC 13F CIK: 0001737088
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q3 2024 · 543 positions · Total reported value $173.41M · Top-10 concentration 29.8% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 40.8% · 17 new · 55 cut · 26 exited
Active Share (vs S&P 500): 78.8% · vs QQQ: 87.1% — share of the book that differs from index weights (higher = more active) · ranking
In its Q3 2024 13F filing, Castleview Partners, LLC disclosed 543 equity positions with a combined reported value of $173.41M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 29.8% of reported value. HoldingsHub classifies the profile as Small / High Turnover.
The largest disclosed positions as of Q3 2024 were MBSF ($21.29M), AAPL ($5.85M), AMGN ($3.73M). By sector, the heaviest allocations are Consumer Discretionary 13.1%, Technology 10.5%. Versus the prior quarter, allocation shifted toward Health Care (+2.4pp), Consumer Discretionary (+1.4pp) and away from Other (-7.0pp).
Versus the prior quarter, Castleview Partners, LLC opened 17 new positions, trimmed 55 and fully exited 26, a turnover rate of 40.8% of positions. The portfolio's overlap with the prior quarter was 52% of names.
The largest new positions opened in Q3 2024 were CLOB ($966.41K), AHR ($494.20K), ETHE ($326.18K).
Of the 26 positions fully exited versus the prior quarter, the largest were QQQ ($1.28M), URNM ($1.27M), TXSS ($1.01M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q3 2024)
- CLOB VANECK AA-BB CLO ETF · $966.41K
- AHR AMERICAN HEALTHCARE · $494.20K
- ETHE GRAYSCALE ETHEREUM STAKING E · $326.18K
- BXSL BLACKSTONE SECD LENDING FD · $301.80K
- VGK VANGUARD FTSE EUROPE ETF · $244.23K
- WMG WARNER MUSIC GROUP CORP CLASS A · $239.24K
- GSY INVESCO ACTIVELY MANAGED EXC · $226.36K
- BTC GRAYSCALE BITCOIN MINI TR ET · $199.28K
Fully Exited (vs previous quarter)
- QQQ INVESCO QQQ TR · prev qtr: $1.28M
- URNM SPROTT URANIUM MINERS ETF · prev qtr: $1.27M
- TXSS TEXAS CAP TEX EQUITY INDEX E · prev qtr: $1.01M
- FDVV FIDELITY COVINGTON TRUST · prev qtr: $969.75K
- OILT TEXAS CAPITAL FUNDS TRUST · prev qtr: $490.87K
- SVOL SIMPLIFY EXCHANGE TRADED FUN · prev qtr: $490.62K
- FLDR FIDELITY MERRIMACK STR TR · prev qtr: $220.00K
- K KELLANOVA · prev qtr: $201.07K
Insider Transactions (Form 4)
Latest Castleview Partners, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Castleview Partners, LLC, based in Dallas, TX, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q3 2026) lists 214 positions worth $228.19M in total. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).
Firm Snapshot
- Headquarters: DALLAS, TX, United States
- SEC registration: 801-106652 (status: Approved), registered 2015-09-11
- Regulatory AUM (Form ADV): $413.03M as of 2026-05-06
- Client mix (by RAUM): individual investors 81%, pooled investment vehicles 19%
- Website: castleviewpartners.com
Portfolio Structure
- 214 positions · $228.19M reported value (Q3 2026)
- Top 10 holdings = 34.6% of reported value
- Largest position: MBSF (VALUED ADVISERS TR) at 10.6%
- Average position size: $1.07M
Sector Tilt
- Health Care 10.6%
- Financials 8.7%
- Information Technology 8.1%
- (classified holdings cover 49% of value)
Quarterly Activity
- Q3 2026: 17 new, 111 added, 55 reduced, 26 exited
- 31 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
830.61K | $21.29M | 12.28% | Add | |
| 2 |
|
25.12K | $5.85M | 3.38% | Reduce | |
| 3 |
|
11.56K | $3.73M | 2.15% | Add | |
| 4 |
|
6.41K | $3.68M | 2.12% | Reduce | |
| 5 |
|
14.71K | $3.58M | 2.06% | Add | |
| 6 |
|
15.63K | $2.91M | 1.68% | Reduce | |
| 7 |
|
60.26K | $2.75M | 1.59% | Add | |
| 8 |
|
6.23K | $2.68M | 1.54% | Reduce | |
| 9 |
|
6.61K | $2.68M | 1.54% | Add | |
| 10 |
|
49.05K | $2.60M | 1.50% | Add | |
| 11 |
|
49.44K | $2.56M | 1.48% | Add | |
| 12 |
|
48.72K | $2.47M | 1.43% | Reduce | |
| 13 |
|
27.08K | $2.25M | 1.30% | Add | |
| 14 |
|
81.56K | $2.07M | 1.19% | Reduce | |
| 15 |
|
18.84K | $1.90M | 1.09% | Add | |
| 16 |
|
21.72K | $1.84M | 1.06% | Add | |
| 17 |
|
6.44K | $1.77M | 1.02% | Add | |
| 18 |
|
84.25K | $1.74M | 1.00% | Add | |
| 19 |
|
9.10K | $1.52M | 0.88% | Reduce | |
| 20 |
|
15.49K | $1.50M | 0.87% | Add | |
| 21 |
|
6.64K | $1.50M | 0.86% | Reduce | |
| 22 |
|
17.67K | $1.47M | 0.85% | Add | |
| 23 |
|
2.84K | $1.40M | 0.81% | Add | |
| 24 |
|
1.45K | $1.38M | 0.80% | Reduce | |
| 25 |
|
13.42K | $1.35M | 0.78% | Reduce | |
| 26 |
|
18.25K | $1.32M | 0.76% | Add | |
| 27 |
|
10.13K | $1.23M | 0.71% | Add | |
| 28 |
|
15.18K | $1.23M | 0.71% | Reduce | |
| 29 |
|
7.80K | $1.17M | 0.68% | Add | |
| 30 |
|
21.78K | $1.15M | 0.66% | Reduce | |
| 31 |
|
354 | $1.12M | 0.64% | Add | |
| 32 |
|
12.38K | $1.09M | 0.63% | Reduce | |
| 33 |
|
1.66K | $1.02M | 0.59% | Add | |
| 34 |
|
96.79K | $1.01M | 0.58% | Add | |
| 35 |
|
8.81K | $985.89K | 0.57% | Hold | |
| 36 |
|
6.30K | $969.79K | 0.56% | Add | |
| 37 |
|
19.25K | $966.41K | 0.56% | New | |
| 38 |
|
2.53K | $949.71K | 0.55% | Hold | |
| 39 |
|
5.24K | $939.55K | 0.54% | Add | |
| 40 |
|
9.21K | $932.37K | 0.54% | Add | |
| 41 |
|
8.04K | $908.33K | 0.52% | Reduce | |
| 42 |
|
4.28K | $902.09K | 0.52% | Add | |
| 43 |
|
5.17K | $895.79K | 0.52% | Add | |
| 44 |
|
8.02K | $887.14K | 0.51% | Reduce | |
| 45 |
|
5.04K | $859.67K | 0.50% | Add | |
| 46 |
|
3.21K | $838.67K | 0.48% | Add | |
| 47 |
|
83 | $814.38K | 0.47% | Reduce | |
| 48 |
|
6.55K | $795.22K | 0.46% | Add | |
| 49 |
|
25.03K | $780.87K | 0.45% | Add | |
| 50 |
|
16.27K | $780.81K | 0.45% | Reduce | |
FAQ
What did Castleview Partners, LLC buy in 2024-Q3?
In its 2024-Q3 13F filing, Castleview Partners, LLC reported 543 equity positions worth $173.41M in aggregate; its largest disclosed positions were MBSF ($21.29M), AAPL ($5.85M), AMGN ($3.73M).
How large is Castleview Partners, LLC's portfolio?
Castleview Partners, LLC reported $173.41M of long equity holdings across 543 positions as of 2024-Q3. Top-10 holdings account for 29.8% of reported value.
What is Castleview Partners, LLC's investment style?
HoldingsHub classifies the portfolio as Small / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.